Bicyclic antagonists selective for the .alpha.v.beta.3 integrin
CA 2378860 A1 · Owner: Zask, Arie · Inventors: Yardley, John; Zask, Arie; Coghlan, Richard Dale
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides novel bicyclic compounds of Formula (I): wherein u v, m, Y, G, A-B, R1, R1a, R2, R4, R5, R5a and R5b are defined in the , specification which compounds exhibit activity as inhibitors of bone resorption and compounds of Formula (II) wherein u v, m, Y, G, D, A-B, R1, R1a, R2, R3, R4 R5, R5a, and R5b are defined in the specification which compounds exhibit activity as inhibitors of bone resorption.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 20, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 20, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 20, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.